Fiasco in the Factory: US Taxpayers Funded a $533 Million Artillery Plant That Made Nothing
Israel Justified Its Wars by Calling Enemies “Crazy.” Now, the Warning Signs All Apply to Israel
Why the Left Lost the Working Class
"When Trump Rode his Vengeance Train Back Into the Oval Office in 2024, one of his First Acts was to Kill all the Lawyers"
Vivek Ramaswamy, a Billionaire and the Republican Nominee in Ohio’s Gubernatorial Race, Served as the Frontman for a Dubious Pharmaceutical Company and Then Cashed out Weeks Before its Dramatic Crash
Can Public Media Build its own Social Network? Chicago Public Media Teams up With New_ Public to try
The Controversy at the Heart of Exxon Began in 1959, When Cuban Revolutionaries Overthrew the American-Friendly Batista Government...
Given Their Self-Conception of Sturdy American Virtues Such as Thrift, Hard Work, and Sobriety, you’d Think the GOP Would be at the Forefront in Opposing Big Weed and Online Gambling
Trump Gets his Maga-Style Teen 'Hunger Games'.
Person Hides Prompt Injection in Legal Filing Telling AI to Side With Them
Fiasco in the Factory: US Taxpayers Funded a $533 Million Artillery Plant That Made Nothing
Israel Justified Its Wars by Calling Enemies “Crazy.” Now, the Warning Signs All Apply to Israel
Why the Left Lost the Working Class
"When Trump Rode his Vengeance Train Back Into the Oval Office in 2024, one of his First Acts was to Kill all the Lawyers"
Vivek Ramaswamy, a Billionaire and the Republican Nominee in Ohio’s Gubernatorial Race, Served as the Frontman for a Dubious Pharmaceutical Company and Then Cashed out Weeks Before its Dramatic Crash
Can Public Media Build its own Social Network? Chicago Public Media Teams up With New_ Public to try
The Controversy at the Heart of Exxon Began in 1959, When Cuban Revolutionaries Overthrew the American-Friendly Batista Government...
Given Their Self-Conception of Sturdy American Virtues Such as Thrift, Hard Work, and Sobriety, you’d Think the GOP Would be at the Forefront in Opposing Big Weed and Online Gambling
Trump Gets his Maga-Style Teen 'Hunger Games'.
Person Hides Prompt Injection in Legal Filing Telling AI to Side With Them

Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

June 2026

July 2026

August 2026

Press releases published on August 13, 2026

Profusa Announces 1-for-4 Reverse Stock Split

Aug. 13, 2026

Profusa Announces 1-for-4 Reverse Stock Split

GlobeNewswire

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Aug. 13, 2026

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

GlobeNewswire

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug. 13, 2026

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Aug. 13, 2026

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

GlobeNewswire

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

Aug. 13, 2026

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

GlobeNewswire

Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités

Aug. 13, 2026

Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités

GlobeNewswire

Zealand Pharma Announces Financial Results for the First Half of 2026

Aug. 13, 2026

Zealand Pharma Announces Financial Results for the First Half of 2026

GlobeNewswire

Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

Aug. 13, 2026

Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

GlobeNewswire

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

Aug. 13, 2026

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

GlobeNewswire

Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update

Aug. 13, 2026

Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update

GlobeNewswire

Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants

Aug. 13, 2026

Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants

GlobeNewswire